Atlas Trials

Safety and Efficacy of Oral HX9428 Tablets in Subjects With Wet Age-related Macular Degeneration (wAMD)

Clinical trial NCT07185841 · RECRUITING

Trial details

NCT number
NCT07185841
Sponsor
Fujian Haixi Pharmaceuticals Co., Ltd.
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Wet Age-related Macular Degeneration (AMD)
Start date
2025-07-01
Primary completion
2028-07-01
Enrollment
198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.